Literature DB >> 11172091

Identification of a short amino acid sequence essential for efficient nuclear targeting of the Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8 K8 protein.

Stéphanie Portes-Sentis1, Evelyne Manet1, Géraldine Gourru1, Alain Sergeant1, Henri Gruffat1.   

Abstract

The K8 protein of Kaposi's sarcoma-associated herpesvirus (KSHV)/human herpesvirus-8 is a member of the bZIP family of transcription factors, which has homology with the Epstein-Barr virus transcription and replication factor, EB1. In this report, we have analysed the subcellular localization of the K8 protein and characterized a 12 amino acid sequence rich in basic residues which is responsible for targeting the protein to the cell nucleus. Furthermore, we show that a K8 mutant lacking the nuclear localization sequence can be directed to the nucleus by co-expression with an intact K8 protein, suggesting that K8 homodimerizes in the cytoplasm of the cell in vivo.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11172091     DOI: 10.1099/0022-1317-82-3-507

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  10 in total

1.  New transport peptides broaden the horizon of applications for peptidic pharmaceuticals.

Authors:  J P M Langedijk; T Olijhoek; D Schut; R Autar; R H Meloen
Journal:  Mol Divers       Date:  2004       Impact factor: 2.943

2.  Investigation of the multimerization region of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) protein K-bZIP: the proposed leucine zipper region encodes a multimerization domain with an unusual structure.

Authors:  Salama Al Mehairi; Eleanora Cerasoli; Alison J Sinclair
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

3.  Leucine zipper domain is required for Kaposi sarcoma-associated herpesvirus (KSHV) K-bZIP protein to interact with histone deacetylase and is important for KSHV replication.

Authors:  Francisco Puerta Martínez; Qiyi Tang
Journal:  J Biol Chem       Date:  2012-03-13       Impact factor: 5.157

4.  The Kaposi's sarcoma-associated herpesvirus K8 protein interacts with CREB-binding protein (CBP) and represses CBP-mediated transcription.

Authors:  S Hwang; Y Gwack; H Byun; C Lim; J Choe
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

5.  Detection of a secreted metalloprotease within the nuclei of liver cells.

Authors:  Ryan C Hunt; S Geetha; Courtni E Allen; Klilah Hershko; Robert Fathke; Philip L Kong; Elizabeth Plum; Evi Budo Struble; Kenji Soejima; Scott Friedman; Susan Garfield; S Balaji; Chava Kimchi-Sarfaty
Journal:  Mol Biosyst       Date:  2011-04-11

6.  Intracellular localization map of human herpesvirus 8 proteins.

Authors:  Gaby Sander; Andreas Konrad; Mathias Thurau; Effi Wies; Rene Leubert; Elisabeth Kremmer; Holger Dinkel; Thomas Schulz; Frank Neipel; Michael Stürzl
Journal:  J Virol       Date:  2007-12-12       Impact factor: 5.103

7.  Kaposi's sarcoma-associated herpesvirus K-bZIP protein is necessary for lytic viral gene expression, DNA replication, and virion production in primary effusion lymphoma cell lines.

Authors:  Sylvain Lefort; Louis Flamand
Journal:  J Virol       Date:  2009-03-25       Impact factor: 5.103

8.  Increased tumorigenicity of cells carrying recombinant human herpesvirus 8.

Authors:  N Cloutier; O van Eyll; M-E Janelle; S Lefort; S-J Gao; L Flamand
Journal:  Arch Virol       Date:  2007-10-18       Impact factor: 2.574

9.  Binding of Kaposi's sarcoma-associated herpesvirus K-bZIP to interferon-responsive factor 3 elements modulates antiviral gene expression.

Authors:  Sylvain Lefort; Anton Soucy-Faulkner; Nathalie Grandvaux; Louis Flamand
Journal:  J Virol       Date:  2007-07-25       Impact factor: 5.103

10.  Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 K-bZIP modulates latency-associated nuclear protein-mediated suppression of lytic origin-dependent DNA synthesis.

Authors:  Cyprian Rossetto; Irena Yamboliev; Gregory S Pari
Journal:  J Virol       Date:  2009-06-24       Impact factor: 5.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.